Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSilverwood Brands Plc Regulatory News (SLWD.PL)

Share Price Information for Silverwood Brands Plc (SLWD.PL)

Share Price is delayed by 15 minutes
Get Live Data
10.00    0.00 (0.00%)
Bid:
5.00
Ask:
15.00
Spread: 10.00 (200.00%)
Market Cap: £4.35m
SLWD.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Silverwood Brands Plc Share Chart

Result of General Meeting

8 Mar 2024 11:47

RNS Number : 1875G
Silverwood Brands PLC
08 March 2024
 

8 March 2024

 

Silverwood Brands plc

("Silverwood" or the "Company", together with its subsidiaries, the "Group")

 

Result of General Meeting

 

Silverwood Brands plc (Aquis: SLWD), a holding company established to invest primarily in branded consumer businesses, is pleased to announce that the Resolution to approve the Capital Reduction announced on 20 February 2024 was duly passed by a show of hands at the General Meeting of the Company held today.

 

The total proxy votes were cast as follows:

 

Resolution

For

Against

Total votes cast as % of Issued Share Capital*

Votes Withheld

Number of Votes

% of votes cast

Number of Votes

% of votes cast

Proposed Cancellation of Consideration Shares, Reduction of Share Capital and the release of the Lush Vendors from any and all obligations arising under or in connection with the SPA, Deed of Grant and Powers of Attorney or with immediate effect

37,317,353

100%

0

0%

87.8%

0%

* The Company's issued share capital consists of 270,712,808 Ordinary Shares. Each Ordinary Share carries the right to vote at a general meeting of the Company, and therefore, the total number of voting rights in the Company is 270,712,808. However, it was agreed that the holders of the Consideration Shares would not exercise their voting rights in relation to those shares. Accordingly, the total number of voting rights in the Company that could be exercised at the General Meeting was 42,500,176. The percentage in the table above is the number of shares voted by proxy as a percentage of that total.

 

The Company will now apply to the Court for confirmation of the cancellation of the Share Premium Account and the Consideration Shares. Such confirmation is expected to be received on or around 16 April 2024 and the Capital Reduction is expected to take effect on or around 18 April 2024, when the order of the Court confirming the Capital Reduction has been registered by the Registrar of Companies. Subject to that registration, trading in the Ordinary Shares on the Aquis Growth Market is expected to be restored on or around 19 April 2024.

 

Further announcements will be made as appropriate.

 

Words and expressions defined in the circular to Shareholders dated 20 February 2024 have the same meaning in this announcement. The circular is available on the Company's website at www.silverwoodbrands.com.

 

For further information, please contact: 

 

Silverwood Brands plc

Andrew Gerrie

Paul Hodgins

 

 

info@silverwoodbrands.com

Peterhouse Capital Limited (Aquis Corporate Adviser)

Mark Anwyl

Narisha Ragoonanthun

Brefo Gyasi

+44 (0)20 7469 0930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXQKFBQDBKDPNK
Date   Source Headline
14th May 202610:21 amRNSResult of General Meeting
20th Apr 20267:01 amRNSUnaudited Interim Results
20th Apr 20267:00 amRNSAudited Final Results
31st Dec 20259:58 amRNSDelay to Publication of Audited Results
31st Dec 20259:58 amRNSDelay to Publication of Audited Results
15th Dec 20259:16 amRNSResult of Annual General Meeting
21st Nov 202511:31 amRNSBoard Change and Notice of AGM
3rd Oct 20253:00 pmRNSAppointment of Aquis Corporate Adviser
16th Jul 20254:33 pmRNSDeferred Consideration; Director/PDMR Shareholding
3rd Apr 202512:32 pmRNSLeading Balmonds product now available at Boots
31st Mar 20252:17 pmRNSUnaudited Interim Results to 31 December 2024
2nd Dec 20243:32 pmRNSDirector/PDMR Shareholding
29th Oct 20242:35 pmRNSChange of Accounting Reference Date
10th Oct 20242:47 pmRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSChange of Registered Office Address
30th Sep 20242:06 pmRNSUnaudited Interim Results
25th Jul 20249:18 amRNSResult of General Meeting
1st Jul 202411:33 amRNSProvision of Annual Report; General Meeting Notice
28th Jun 20245:10 pmRNSAnnual report For the year ended 31 December 2023
28th Jun 202412:08 pmRNSResult of AGM
31st May 20244:31 pmRNSNotice of AGM
15th May 20243:46 pmRNSDirector/PDMR Shareholding - Correction
14th May 202412:33 pmRNSDirector/PDMR Shareholding
7th May 202412:04 pmRNSDirector/PDMR Shareholding
1st May 202411:57 amRNSHolding in Company
1st May 20247:00 amRNSTrading Update
30th Apr 202412:16 pmRNSCapital Reduction complete; Restoration of Trading
19th Apr 20247:00 amRNSDelayed Restoration of Trading
2nd Apr 20247:00 amRNSAcquisition of Cosme Science Corporation
8th Mar 202411:47 amRNSResult of General Meeting
1st Mar 20247:00 amRNSAcquisition of Cosme Science Corporation
20th Feb 20244:54 pmRNSProposed Capital Reduction and Notice of GM
31st Jan 20243:22 pmRNSTotal Voting Rights
29th Jan 20241:30 pmRNSTrading Update
29th Jan 20241:30 pmRNSUnaudited Interim Results
10th Jan 20247:00 amRNSSettlement Deed
13th Oct 20231:12 pmRNSLoan Extension and Waiver
9th Oct 20233:54 pmRNSUpdate on Legal Proceedings
2nd Oct 20237:00 amRNSDirectorate Change
2nd Oct 20237:00 amRNSUpdate on Defence Extension; Temporary Suspension
21st Sep 20237:00 amRNSChange of Corporate Adviser
19th Sep 202311:05 amRNSUpdate on Defence Extension
14th Aug 20237:00 amRNSAcknowledgement of Service & Defence Extension
27th Jul 20237:00 amRNSLush transaction update; legal proceedings notice
26th Jul 202310:21 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.